Thema
Journal Article
107
Influenza Vaccines
62
Research Support, Non-U.S. Gov't
48
Vaccines, Attenuated
44
Antibodies, Viral
38
Influenza
22
615
20
che
20
Review
19
bio
19
live attenuated influenza vaccine
17
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
16
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
15
Live attenuated influenza vaccine
12
influenza
12
Antibodies, Neutralizing
11
Hemagglutinin Glycoproteins, Influenza Virus
11
Randomized Controlled Trial
10
SARS-CoV-2
9
Vaccines, Inactivated
9
Pandemics
8
immunogenicity
8
Immunoglobulin A
7
Influenza Virus
7
Neuraminidase
7
Vaccines
7
Viruses
7
universal influenza vaccine
7
Clinical Trial, Phase I
6
Comparative Study
6
Viral Proteins
6
cross-protection
6
Cross-protection
5
EC 3.2.1.18
5
Editorial
5
Immunoglobulin G
5
Universal influenza vaccine
5
Vaccines, Synthetic
5
safety
5
A61K
4
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
4
C12N
4
COVID-19
4
Epitopes
4
Epitopes, T-Lymphocyte
4
Hemagglutination Inhibition
4
LAIV
4
Pre-pandemic vaccine
4
Research Support, N.I.H., Extramural
4
clinical trial
4
mehr ...